Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.

Literature DB >> 21908511

Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.

M Mandalà¹, A Falanga, F Roila.

Abstract

Entities: Disease Species

Mesh：

Year: 2011 PMID： 21908511 DOI： 10.1093/annonc/mdr392

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

134 in total

1. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.

Authors: Lauren S Prescott; Lisa M Kidin; Rebecca L Downs; David J Cleveland; Ginger L Wilson; Mark F Munsell; Alma Y DeJesus; Katherine E Cain; Pedro T Ramirez; Michael H Kroll; Charles F Levenback; Kathleen M Schmeler
Journal: Int J Gynecol Cancer Date: 2015-01 Impact factor: 3.437

Review 2. Venous thromboprophylaxis in urological cancer surgery.

Authors: Wojciech Michalski; Grazyna Poniatowska; Joanna Jonska-Gmyrek; Jakub Kucharz; Pawel Stelmasiak; Karol Nietupski; Katarzyna Ossolinska-Skurczynska; Michal Sobieszczuk; Tomasz Demkow; Pawel Wiechno
Journal: Med Oncol Date: 2019-11-25 Impact factor: 3.064

Review 3. Deep Vein Thrombosis Interventions in Cancer Patients.

Authors: Resmi Ann Charalel; Suresh Vedantham
Journal: Semin Intervent Radiol Date: 2017-03 Impact factor: 1.513

Review 4. Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

Authors: Minh Phan; Sonia John; Ana I Casanegra; Suman Rathbun; Aaron Mansfield; Julie A Stoner; Alfonso J Tafur
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

Review 5. Supportive care in pancreatic ductal adenocarcinoma.

Authors: B Laquente; A Calsina-Berna; A Carmona-Bayonas; P Jiménez-Fonseca; I Peiró; A Carrato
Journal: Clin Transl Oncol Date: 2017-06-13 Impact factor: 3.405

6. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

Authors: J C Easaw; M A Shea-Budgell; C M J Wu; P M Czaykowski; J Kassis; B Kuehl; H J Lim; M MacNeil; D Martinusen; P A McFarlane; E Meek; O Moodley; S Shivakumar; V Tagalakis; S Welch; P Kavan
Journal: Curr Oncol Date: 2015-04 Impact factor: 3.677

Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.

1. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.

Review 2. Venous thromboprophylaxis in urological cancer surgery.

Review 3. Deep Vein Thrombosis Interventions in Cancer Patients.

Review 4. Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

Review 5. Supportive care in pancreatic ductal adenocarcinoma.

6. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

Review 7. Thrombosis in cancer patients: etiology, incidence, and management.

8. Thromboembolic disease in patients with high-grade glioma.

9. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.

10. Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.